User profiles for Matteo Bauckneht
 | Matteo BaucknehtNuclear Medicine, Dept. of Health Sciences (DISSAL), University of Genoa, Italy Verified email at unige.it Cited by 2589 |
Dopaminergic imaging and clinical predictors for phenoconversion of REM sleep behaviour disorder
…, J Trnka, T Miyagawa, A Serra, F Pizza, M Bauckneht… - Brain, 2021 - academic.oup.com
This is an international multicentre study aimed at evaluating the combined value of dopaminergic
neuroimaging and clinical features in predicting future phenoconversion of idiopathic …
neuroimaging and clinical features in predicting future phenoconversion of idiopathic …
[HTML][HTML] A 3D deep learning model to predict the diagnosis of dementia with Lewy bodies, Alzheimer's disease, and mild cognitive impairment using brain 18F-FDG …
Purpose The purpose of this study is to develop and validate a 3D deep learning model that
predicts the final clinical diagnosis of Alzheimer’s disease (AD), dementia with Lewy bodies (…
predicts the final clinical diagnosis of Alzheimer’s disease (AD), dementia with Lewy bodies (…
Early identification of MCI converting to AD: a FDG PET study
Purpose Mild cognitive impairment (MCI) is a transitional pathological stage between normal
ageing (NA) and Alzheimer’s disease (AD). Although subjects with MCI show a decline at …
ageing (NA) and Alzheimer’s disease (AD). Although subjects with MCI show a decline at …
Doxorubicin effect on myocardial metabolism as a prerequisite for subsequent development of cardiac toxicity: a translational 18F-FDG PET/CT observation
M Bauckneht, G Ferrarazzo, F Fiz… - Journal of Nuclear …, 2017 - Soc Nuclear Med
The present translational study aimed to verify whether serial 18 F-FDG PET/CT predicts
doxorubicin cardiotoxicity. Methods: Fifteen athymic mice were treated intravenously with saline …
doxorubicin cardiotoxicity. Methods: Fifteen athymic mice were treated intravenously with saline …
[HTML][HTML] Brain metabolic correlates of persistent olfactory dysfunction after SARS-Cov2 infection
MI Donegani, A Miceli, M Pardini, M Bauckneht… - Biomedicines, 2021 - mdpi.com
We aimed to evaluate the brain hypometabolic signature of persistent isolated olfactory
dysfunction after SARS-CoV-2 infection. Twenty-two patients underwent whole-body [ 18 F]-FDG …
dysfunction after SARS-CoV-2 infection. Twenty-two patients underwent whole-body [ 18 F]-FDG …
18F-NaF uptake by atherosclerotic plaque on PET/CT imaging: inverse correlation between calcification density and mineral metabolic activity
Several studies have highlighted the role of vascular 18 F-NaF uptake as a marker of
ongoing calcium deposition. However, accumulation of 18 F-NaF is often inconsistent with …
ongoing calcium deposition. However, accumulation of 18 F-NaF is often inconsistent with …
Presynaptic dopaminergic neuroimaging in REM sleep behavior disorder: a systematic review and meta-analysis
The presence of polysomnography-confirmed REM sleep behavior disorder (RBD) is the
stronger risk factor for having prodromal Parkinson disease (PD), followed by abnormal …
stronger risk factor for having prodromal Parkinson disease (PD), followed by abnormal …
Metabolic correlates of dopaminergic loss in dementia with Lewy bodies
…, E Peira, D Arnaldi, M Bauckneht… - Movement …, 2020 - Wiley Online Library
Background Striatal dopamine deficiency and metabolic changes are well‐known phenomena
in dementia with Lewy bodies and can be quantified in vivo by 123 I‐Ioflupane brain …
in dementia with Lewy bodies and can be quantified in vivo by 123 I‐Ioflupane brain …
[HTML][HTML] The prognostic power of inflammatory indices and clinical factors in metastatic castration-resistant prostate cancer patients treated with radium-223 (BIO-Ra …
M Bauckneht, SE Rebuzzi, A Signori… - European Journal of …, 2022 - Springer
Purpose To combine peripheral blood indices and clinical factors in a prognostic score for
metastatic castration-resistant prostate cancer (mCRPC) patients treated with radium-223 …
metastatic castration-resistant prostate cancer (mCRPC) patients treated with radium-223 …
[HTML][HTML] Immune checkpoint inhibitors in advanced prostate cancer: current data and future perspectives
Simple Summary The treatment landscape of advanced prostate cancer (PCa) is constantly
improving with the approval of many new therapeutic options. Immunotherapy in PCa has …
improving with the approval of many new therapeutic options. Immunotherapy in PCa has …